Target intelligence / Profile preview

Shelterin complex (Shelterin)

Target
Shelterin
Molecular classification
Protein complex, Telomere-binding proteins, DNA-binding protein complex
01

Overview

The Shelterin complex, also known as the telosome, is a specialized six-protein assembly consisting of TRF1, TRF2, POT1, TIN2, TPP1, and RAP1 that binds specifically to telomeric DNA to maintain genomic integrity. Its primary biological function is to cap the ends of chromosomes, sequestering the 3' single-stranded telomeric overhang into a protective T-loop structure that prevents the DNA damage response (DDR) machinery from recognizing chromosome ends as double-strand breaks. By inhibiting ATM and ATR kinase signaling and repressing repair pathways like non-homologous end joining (NHEJ) and homology-directed repair (HDR), the complex prevents chromosomal fusions and instability. In many cancers, the shelterin complex is dysregulated to facilitate telomere maintenance and cellular immortality, making it a high-priority therapeutic target. Pharmacological interventions include G-quadruplex stabilizers that displace shelterin proteins and small molecules designed to disrupt critical protein-protein interactions within the complex. Such treatments aim to induce telomere uncapping, triggering senescence or apoptosis specifically in malignant cells. However, a significant therapeutic challenge remains the potential for off-target effects on healthy stem cells and the risk of inducing widespread genomic instability.

Other names
TelosomeTelomere-binding protein complexShelterinTelomere-specific protein complex
02

Mechanism of action

Disruption of telomere capping to induce DNA damage response (ATM/ATR activation), inhibition of telomerase access to the 3' overhang, and stabilization of G-quadruplex structures to displace shelterin components.

03

Biological functions

Telomere protectionTelomere length regulationDNA damage response suppressionT-loop formationTelomerase recruitmentChromosome end capping
04

Disease associations

CancerAgingDyskeratosis congenitaIdiopathic pulmonary fibrosisHoyeraal-Hreidarsson syndrome
05

Safety considerations

Genomic instability in healthy tissuesToxicity to hematopoietic stem cellsOff-target DNA damage response activationChallenges in targeting protein-protein interactions (PPIs)
06

Interacting drugs

BRACO-19

5 more in the full profile.

07

Biomarkers

Telomere lengthTERF1 expression levelsTERF2 expression levelsPOT1 mutation statushTERT expressionTIN2 mutation status

Beyond the preview

Go deeper on Shelterin complex (Shelterin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shelterin complex (Shelterin).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call